Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Care to Prevent Oral Mucositis in Breast Cancer Patients Treated With Everolimus
NCT02376985Phase 3Completed
- Sponsor
- Comprehensive Support Project for Oncology Research
- Start
- Mar 2015
- Primary completion
- Mar 2018
- Countries
- 1
01
Overview
Phase 3, randomised trial in oral mucositis (OM) (2 arms), sponsored by Comprehensive Support Project for Oncology Research. Primary endpoint: Incidence of oral mucositis (Over Grade 1) after everolimus treatment at 8 weeks. Started Mar 2015; status: completed.
02
Conditions
oral mucositis (OM)
Beyond the preview
Go deeper on NCT02376985.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02376985.